Climate Report Signals Potential NearRecord Heat Waves Raising Stakes for Insurance and Energy Sectors Global Uncertainty Drags Down Overseas Remittances Under LRS by 2 in FY26 RBI Data Shows Rubio Moves to Calm NATO Allies Amid Uncertainty Over US Troop Deployments MuskAltman Trial Could Boost AI Industry Transparency SpaceXs Deleted S1 Disclosure Reveals Stunning Economics of AI Infrastructure Deal with Anthropic AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices CZNC Q1 2026 Earnings Massive EPS Miss Shocks Analysts Stock Holds Steady NCLH Q1 2026 Earnings EPS Beat by 583 Drives Strong Stock Surge IVR Q1 2026 Earnings Mortgage REIT Slightly Misses EPS Estimates Amid Market Volatility OVV Q1 2026 Earnings Strong EPS Beat as Operational Efficiency Drives Surprise TLSI Q1 2026 Earnings EPS Surprises Positively Despite No Revenue Stock Declines Ryder System Inc R Q1 2026 Earnings EPS Surprises 965 Above Estimates Lifezone Metals Soars 876 Support and Resistance Levels in Focus Meiwu Technology WNW Drops 4 as Selling Pressure Builds Near Key Support Level Tennessee Valley Authority TVE Holds Steady Near Support as Utilities Sector Shows Resilience Presidio Property Trust Preferred Stock SQFTP Edges Higher Amid Steady Trading Natures Sunshine Products NATR Holds Steady Near 2184 as Technical Levels Come into Focus SpaceX Scrubs Starship V3 Test Flight Rescheduled for Friday Launch 3D Systems DDD Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Rally Deutsche Bank DB Edges Lower Amid Market Uncertainty Key Levels to Watch Biofrontera Inc BFRI Edges Higher A SmallCap Biotech Finds Temporary Footing Scully Royalty Ltd SRL Holds Steady at 612 as Traders Eye Key Resistance Arcutis Biotherapeutics ARQT Moves Higher as Market Digests Recent Developments Creative Global Technology Holdings Limited CGTL Slips 6 as Stock Tests Key Support Levels Zura Bio ZURA Slips 18 as Stock Tests Key Support Levels San Juan Basin Royalty Trust SJT Edges Lower as Energy Sector Consolidates Zentalis Pharmaceuticals ZNTL Faces Resistance Near 426 After Recent Pullback